KALA - Kala Pharmaceuticals - Stock Forecast

Healthcare - Sector
Coverage Stock analysts Price Targets & Ratings Chart Insider Trading

KALA is currently covered by 3 analysts with an average price target of $278.08. This is a potential upside of $273.9 (6552.63%) from yesterday's end of day stock price of $4.18.

Kala Pharmaceuticals's activity chart (see below) currently has 15 price targets and 47 ratings on display. The stock rating distribution of KALA is 100% BUY.

Stock Analyst Price Targets - Review

Analysts average stock forecasts to be materialized ratio is 5.06% with an average time for these price targets to be met of 26.63 days.

Highest price target for KALA is $15, Lowest price target is $12, average price target is $14.

Most recent stock forecast was given by ANDREAS ARGYRIDES from OPPENHEIMER on 02-Jun-2025. First documented stock forecast 14-Aug-2017.

Currently out of the existing stock ratings of KALA, 13 are a BUY (100%).

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Buy

$15

$10.7 (248.84%)

$22

15 days ago
(02-Jun-2025)

0/3 (0%)

$11.48 (326.14%)

Buy

$12

$7.7 (179.07%)

$15

25 days ago
(23-May-2025)

1/14 (7.14%)

$7.96 (197.03%)

65

Buy

$15

$10.7 (248.84%)

$15

9 months 29 days ago
(19-Aug-2024)

0/3 (0%)

$8.72 (138.85%)

Buy

2 years 10 months 2 days ago
(15-Aug-2022)

0/2 (0%)

$390 (108.33%)

Sell

3 years 2 months 18 days ago
(30-Mar-2022)

0/2 (0%)

$815 (87.17%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

What is KALA (Kala Pharmaceuticals) average time for price targets to be met?

On average it took 26.63 days on average for the stock forecasts to be realized with a an average price target met ratio 5.06

Which analyst has the current highest performing score on KALA (Kala Pharmaceuticals) with a proven track record?

FRANCOIS BRISEBOIS

Which analyst has the current lower performing score on KALA (Kala Pharmaceuticals) with a proven track record?

RAGHURAM SELVARAJU

Which analyst has the most public recommendations on KALA (Kala Pharmaceuticals)?

Francois Brisebois works at OPPENHEIMER and has 3 price targets and 2 ratings on KALA

Which analyst is the currently most bullish on KALA (Kala Pharmaceuticals)?

Tazeen Ahmad with highest potential upside - $791.1

Which analyst is the currently most reserved on KALA (Kala Pharmaceuticals)?

Chris Schott with lowest potential downside - -$0

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?